$CRSP announced that Health Canada has approved its Clinical Trial Application (CTA) for VCTX210, an allogeneic gene-edited, stem cell-derived therapy for the treatment of type 1 #diabetes (T1D). Initiation of patient enrollment is expected by year-end. #CRISPR#Genomics#FinTwit
Prof Wojciech Chrzanowski @wchrzanowski is now presenting his inspiring research on harnessing EV for tissue repair. It’s exciting to see more potential therapeutic applications of EVs #ANZSEV2021
'Studying mice, researchers at @WUSTLmed in St. Louis have developed a method of stem cell transplantation that does not require radiation or chemotherapy.' https://t.co/vEHMdfdupM Paper: https://t.co/0uPjNF4VqO
'The American stem cell sell in 2021: U.S. businesses selling unlicensed and unproven stem cell interventions.' @LeighGTurner Paper: https://t.co/nERf2hJPV3 https://t.co/qAnstFZ3tN
EV lovers! The #ANZSEVECR chat on “EV methodologies”, chaired by A/Prof Carlos Salomon @cfsalomo (U of Qld) and Dr Richard Wilson (U of Tas), is specifically organised for you. So bring any EV-related questions, concerns, or experience you have along! #ANZSEV2021
‘University of Queensland scientist Ernst Wolvetang hopes the novel approach will take the guesswork out of prescribing seizure drugs to epilepsy patients, a process that is often a long journey of trial and error for neurologists.’@Wolvejong@UQ_News https://t.co/JlrJfGomja
Did you know that we make billions of blood cells every day? In the Stem Cell Regulation Unit we Investigate how blood-forming stem cells (the ancestor of all blood cells) are regulated to produce all blood cell types, in normal circumstances & in diseases like cancer. 1/4
‘The Australian Government is boosting Australian led stem cell research through $25 million in grants, to help find and develop innovative, safe and effective treatments for devastating diseases and injuries.’ https://t.co/BIw4OKwCtx
Cord blood banking and tissue cryopreservation company uplists and is now on the NASDAQ. Will future of regen med increasingly involve shareholders as stakeholders?
Should the public hear about every scientific and medical side effect when considering any new therapy? Do we assume everyone has the same appetite for risk? Should we avoid provocation of anxiety? Does one size fit all?
https://t.co/nOBdd7fOZa
Concerning to see that intranasal stem cell delivery may have already been promoted and administered despite being not 'well-studied' and potentially presenting 'unique risks.' #stemcells
Interesting paper that attempts to charecterise extracellular microRNAs (miRNAs) & small extracellular vesicles (sEVs) from stromal vascular fraction (SVF) of healthy and lipedema adipose tissue (AT). Lipedema is a chronic, progressive disease of AT. https://t.co/c3xeX4VCJt